ArticleNeuro-oncology advances

CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases.

Ramin A Morshed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.